Histologic and functional evaluation of lungs reconditioned by ex vivo lung perfusion


Autoria(s): Medeiros, Israel Lopes; Pego-Fernandes, Paulo Manuel; Mariani, Alessandro Wasum; Fernandes, Flavio Guimaraes; Unterpertinger, Fernando do Vale; Canzian, Mauro; Jatene, Fabio Biscegli
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

24/10/2013

24/10/2013

2012

Resumo

BACKGROUND: Only about 15% of donor lungs are considered suitable for transplantation (LTx). Ex vivo lung perfusion (EVLP) has been developed as a method to reassess and repair damaged lungs. We report our experience with EVLP in non-acceptable donor lungs and evaluate its ability to recondition these lungs. METHODS: We studied lungs from 16 brain-dead donors rejected for LTx. After harvesting, the lungs were stored at 4 degrees C for 10 hours and subjected to normothermic EVLP with Steen Solution (Vitro life, Goteborg, Sweden) for 60 minutes. For functional evaluation, the following variables were assessed: partial pressure of arterial oxygen (Pao(2)), pulmonary vascular resistance (PVR), and lung compliance (LC). For histologic assessment, lung biopsy was done before harvest and after EVLP. Tissue samples were examined under light microscopy. To detect and quantify apoptosis, terminal deoxynucleotide transferase-mediated deoxy uridine triphosphate nick-end labeling assay was used. RESULTS: Thirteen lima donors were refused for having impaired lung function. The mean Pao(2) obtained in the organ donor at the referring hospital was 193.7 mm Hg and rose to 489 mm Hg after EVLP. During EVLP, the mean PVR was 652.5 dynes/sec/cm(5) and the mean LC was 48 ml/cm H2O. There was no significant difference between the mean Lung Injury Score before harvest and after EVLP. There was a trend toward a reduction in the median number of apoptotic cells after EVLP. CONCLUSIONS: EVLP improved lung function (oxygenation capacity) of organs considered unsuitable for transplantation. Lung tissue structure did not deteriorate even after 1 hour of normothermic perfusion. J Heart Lung Transplant 2012;31:305-9 (C) 2012 International Society for Heart and Lung Transplantation. All rights reserved.

Fundacao de Amparo a Pesquisa do Estado de So Paulo (FAPESP)

Fundacao de Amparo a Pesquisa do Estado de So Paulo (FAPESP)

Braile Biomedica (Sao Jose do Rio Preto, SP, Brazil)

Braile Biomedica (Sao Jose do Rio Preto, SP, Brazil)

Farmoterapica (Sao Paulo, SP Brazil)

Farmoterapica (Sao Paulo, SP Brazil)

Vitrolife (Goteborg, Sweden)

Vitrolife, Goteborg, Sweden

Identificador

JOURNAL OF HEART AND LUNG TRANSPLANTATION, NEW YORK, v. 31, n. 3, supl. 1, Part 6, pp. 305-309, MAR, 2012

1053-2498

http://www.producao.usp.br/handle/BDPI/35969

10.1016/j.healun.2011.10.005

http://dx.doi.org/10.1016/j.healun.2011.10.005

Idioma(s)

eng

Publicador

ELSEVIER SCIENCE INC

NEW YORK

Relação

JOURNAL OF HEART AND LUNG TRANSPLANTATION

Direitos

closedAccess

Copyright ELSEVIER SCIENCE INC

Palavras-Chave #EX VIVO LUNG PERFUSION #LUNG TRANSPLANTATION #BRAIN-DEAD DONORS #DONOR LUNGS #TRANSPLANTATION #PRESERVATION #INJURY #MODEL #CARDIAC & CARDIOVASCULAR SYSTEMS #RESPIRATORY SYSTEM #TRANSPLANTATION
Tipo

article

original article

publishedVersion